Plaintiffs have filed two putative class action complaints in 2023, alleging violations of New York City’s relatively new biometric information privacy law, signaling a new potential avenue for class action plaintiffs’ lawyer...more
The cannabis world is abuzz with news about the latest federal Food & Drug Administration (FDA) report regarding cannabidiol (CBD). We break down what it is, and what it means for the industry and the regulatory landscape for...more
3/9/2020
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Corporate Counsel ,
Department of Health and Human Services (HHS) ,
E-Cigarettes ,
Enforcement Programs ,
Food and Drug Administration (FDA) ,
Information Reports ,
Regulatory Agencies ,
Regulatory Agenda